KA
CL icon

Kovack Advisors’s Colgate-Palmolive CL Stock Holding History

Kovack Advisors’s Portfolio CL Stock Details CL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$636K Buy
6,875
+170
+3% +$14.9K 0.03% 541
2026
Q1 		$572K Buy
6,705
+227
+4% +$20.2K 0.03% 553
2025
Q4 		$512K Buy
6,478
+1,509
+30% +$118K 0.02% 586
2025
Q3 		$397K Buy
4,969
+175
+4% +$14.9K 0.04% 390
2025
Q2 		$436K Buy
4,794
+114
+2% +$10.4K 0.04% 373
2025
Q1 		$438K Buy
4,680
+27
+0.6% +$2.42K 0.05% 335
2024
Q4 		$423K Buy
4,653
+203
+5% +$19.4K 0.04% 351
2024
Q3 		$462K Buy
4,450
+202
+5% +$20.6K 0.05% 323
2024
Q2 		$412K Sell
4,248
-497
-10% -$45.8K 0.05% 348
2024
Q1 		$427K Buy
4,745
+865
+22% +$73.3K 0.05% 283
2023
Q4 		$309K Buy
3,880
+603
+18% +$45.3K 0.04% 409
2023
Q3 		$233K Buy
+3,277
New +$245K 0.03% 448
2018
Q4 		– Sell
-3,328
Closed -$223K – 432
2018
Q3 		$223K Buy
+3,328
New +$222K 0.06% 368

Other funds holding CL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Kovack Advisors's CL Position: Q2 2026 in Review

Kovack Advisors increased its Colgate-Palmolive (CL) stake by 2.5% in Q2 2026, buying an estimated $14.9K and bringing the position to 6,875 shares worth $636K. The position accounts for 0.03% of the portfolio, ranked #541.

Kovack Advisors first reported a position in CL in Q3 2018 and has held it in 13 quarters since. 2,020 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • Kovack Advisors held 6,875 shares of Colgate-Palmolive worth $636K as of Q2 2026.
  • Kovack Advisors bought 170 Colgate-Palmolive shares in Q2 2026, an estimated $14.9K.
  • Colgate-Palmolive made up 0.03% of Kovack Advisors's portfolio in Q2 2026, its #541 holding.
  • Kovack Advisors first reported a position in Colgate-Palmolive in Q3 2018 and has held it in 13 quarters since.
  • 2,020 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Kovack Advisors's 13F filing for Q2 2026, filed 29 Jul 2026.